Facebook
X
LinkedIn
Forward
Integrating Palliative Approaches in Caring for Patients with Sickle Cell Disease Microlearning Series
SCD is a severe, complex condition involving acute and chronic complications that significantly affect morbidity and mortality, demanding ongoing, multidisciplinary care. Patients frequently encounter disparities in access to pain management and palliative services. This activity integrates a case-based, expert-led approach to illustrate the profound benefits of incorporating early and continuous palliative care across the lifespan, addressing the physical, emotional, and spiritual needs of this underserved population. Upon completion of this activity, learners will demonstrate the ability to apply evidence-based strategies to manage pain and non-pain symptoms, lead equitable care planning discussions, and evaluate care delivery models that integrate palliative principles into SCD management. These skills support improved patient quality of life, enhanced interdisciplinary collaboration, and the reduction of healthcare disparities.
Target Audience
This activity is designed for interdisciplinary healthcare professionals involved in the care of individuals living with Sickle Cell Disease (SCD), including palliative care specialists, physicians, nurses, advanced practice providers, social workers, psychologists, chaplains, and other members of the care team. It is also relevant for clinicians seeking to enhance their skills in pain and symptom management, psychosocial support, and patient-centered care models to improve outcomes for this underserved population.
Learning Outcomes
Following participation in this activity, learners will be able to:
- Recognize SCD as a serious illness and articulate its impact on patients’ quality of life.
- Apply evidence-based best practices for managing pain, non-pain symptoms, and advance care planning in patients with SCD.
- Integrate trauma-informed care principles and anti-racist frameworks into the management of SCD patients.
- Evaluate models of care delivery that support palliative integration for individuals with SCD.
Disclosures
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.
*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.
All editors, faculty and staff have disclosed no relevant financial relationships.
*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients.
Disclousure of Commercial Support
This continuing medical education activity is supported by an independent educational grant from Agios Pharmaceuticals, Inc.
The supporter had no influence over any aspect of the activity, including planning, content development, faculty selection, or execution. All content has been developed independently by the planning committee and faculty in accordance with the ACCME Standards for Integrity and Independence.
Faculty
Ashley N. Allen, MD MSPH
Lasé Ajayi, MD FAAHPM FAAP
Craig Blinderman, MD MA
Dana Guyer, MD
Rushil Patel, MD
Eberechi Nwogu-Onyemkpa, MD
Emily Cotter MD MPH
Stephanie Kiser, MD MPH
Staff
Emily Geary, BA
Julie Tanner, BSN RN-BC CHPN
Laura Witt, MS-HSM
Julie Bruno, MSW LCSW
Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Hospice and Palliative Medicine (AAHPM) designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion includes attesting to meaningful activity participation and completion/submission of activity evaluation within the time frame designated.
Evaluation period closes June 30, 2027 for claiming CME credit.
Maintenance of Certification (MOC) Recognition Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Integrating Palliative Approaches in Caring for Patients with Sickle Cell Disease Microlearning Series (apply toward general CME requirement) for the following ABMS Member Boards:
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 MOC Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 2.25 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program.
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. By submitting your evaluation, you grant AAHPM permission to submit completion information to ACCME for the purpose of granting respective BOARD MOC program credit or points as applicable. De-identified aggregated data from the evaluation may be used for research and/or publication and will conform to generally accepted standards of experimental design, data collection and analysis where indicated.
Evaluation period closes June 30, 2027 for claiming MOC credit.
Available Credit
- 2.25 ABIM MOC
- 2.25 ABP MOC
- 2.25 CME (physician only)
- 2.25 Participation